- Deals, deals, deals; Biohaven takes on Eli Lilly; and moreWelcome back to Endpoints Weekly! Don’t miss Ryan Cross’ deep dive into the paranoia caused by competition with China. Ryan writes that US biotech companies are holding their cards close to the ...Endpoints · 16d ago↗ source
- Apnimed files for IPO as FDA reviews its sleep apnea drugApnimed is finally going forward with an IPO attempt after years of flirting with the milestone. The Cambridge, MA-based biotech revealed its Nasdaq plans on Friday night, following a strong six ...Endpoints · 16d ago↗ source
- FDA returns to releasing pharma rejection letters with 14 new CRLsThe FDA on Friday posted 14 new rejection letters to pharma companies online, days after HHS confirmed to Endpoints News that the agency had paused new CRL releases because of a pharma-backed ...